Silverarc Capital Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Silverarc Capital Management, LLC

  • $353 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$1.14 - $2.09 $483,566 - $886,538
-424,181 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$1.67 - $2.76 $473,531 - $782,603
-283,552 Reduced 40.06%
424,181 $827,000
Q3 2021

Nov 15, 2021
BUY
$2.62 - $3.45 $241,527 - $318,041
92,186 Added 14.98%
707,733 $1.94 Million
Q2 2021

Aug 16, 2021
BUY
$1.96 - $3.15 $1.21 Million - $1.94 Million
615,547 New
615,547 $1.94 Million

Others Institutions Holding VTGN

# of Institutions
2
Shares Held
2.7M
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $623M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email